Failure to Follow Up on Abnormal Antiseizure Lab Results
Summary
The facility failed to implement and operationalize procedures to ensure follow-up assessment and monitoring of abnormal laboratory testing results for a resident with epilepsy, Alzheimer’s disease, intellectual disabilities, bipolar disorder, and cerebral palsy. The resident was severely cognitively impaired, required substantial to maximal assistance with ADLs, and had a history of falls, including falls related to seizure activity. The resident was receiving Keppra 1000 mg every 8 hours and Depakote 500 mg three times daily, with orders for Keppra level, valproic acid level, hepatic function, and CBC monitoring at baseline and every 6 months. The record showed multiple seizure-related events and falls. After a seizure and fall from a wheelchair in the activity room, the resident was assessed, returned to the room, and given rectal Diazepam. The documented intervention after that event included asking nursing staff to be alerted when seizure activity was noted and placing a neuro monitoring order. Another seizure and fall occurred later when the resident was found on the floor in the room; the resident was again assessed, assisted into bed, and given rectal Diazepam. The immediate intervention documented after that event was to draw a Keppra level at the next lab draw. Laboratory review showed a Keppra level of 55.2 ug/mL in February and an elevated Keppra level of 89.9 ug/mL in March. The elevated result was scanned into the EMR, but there was no redraw and no dose adjustment documented. Nursing staff did not identify any notes showing that the HCP was contacted about the elevated level or that a repeat lab was advocated for. A later lab entry in July showed valproic acid at 69 ug/mL and Keppra listed as pending, but the facility did not have the Keppra result available at the time of review. During interview, the Administrator and DON acknowledged the concern and stated there was no explanation for why the abnormal Keppra result was not followed up and why the later Keppra result had not been obtained.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release August 26, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.